Antoine Dauphin
Public Communications Contact at Cathay Capital Private Equity SAS
Network origin in Antoine Dauphin first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Cathay Capital Private Equity SAS
 Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France.
31
| Private Company | Investment Managers | 31 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Antoine Dauphin via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ESCP Europe Campus Paris | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Sciences Po | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree | |
| China Europe International Business School | College/University | Undergraduate Degree Masters Business Admin | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
| ZBOM HOME COLLECTION CO.,LTD | Home Furnishings | Director/Board Member Director/Board Member | |
| Escp Business School | College/University | Undergraduate Degree Masters Business Admin | |
Phinex SAS
 Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Undergraduate Degree | |
Cathay Innovation SAS
 Cathay Innovation SAS Investment ManagersFinance Cathay Innovation SAS is a venture capital firm, a subsidiary of Cathay Capital Private Equity SAS founded in 2015 by Denis Barrier and Ming Po Cai. Cathay Innovation SAS is headquartered in Paris. | Investment Managers | Corporate Officer/Principal Public Communications Contact | |
Phixen SAS
 Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Université de Versailles Saint-Quentin-en-Yvelines | College/University | Undergraduate Degree | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mint Solutions Holding BV
 Mint Solutions Holding BV Electronic Equipment/InstrumentsElectronic Technology Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
| MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member | |
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
| Health Opportunities GmbH | Chief Executive Officer | ||
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Corporate Officer/Principal | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
DayTwo Ltd.
 DayTwo Ltd. Medical/Nursing ServicesHealth Services DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel. | Medical/Nursing Services | Director/Board Member | |
| Rothschild & Co. Commandité | Compliance Officer | ||
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Dermala, Inc.
 Dermala, Inc. Household/Personal CareConsumer Non-Durables Dermala, Inc. develops treatments for the chronic skin diseases. It focuses on the most prevalent skin diseases like acne and eczema and skin conditions like skin aging. The firm is developing end-to-end solutions that will consist of microbiome analysis, personalized topical and oral treatments and an app for tracking the treatment outcome and treatment optimization via data analytics, machine learning and AI. The company was founded by Lada Rasochova in 2014 and is headquartered in San Diego, CA. | Household/Personal Care | Director/Board Member | |
Ganymed Robotics SAS
 Ganymed Robotics SAS Industrial MachineryProducer Manufacturing Ganymed Robotics SAS develops robots for orthopaedic surgeries. The company was founded by Sophie Cahen in June 26, 2018 and is headquartered in Paris, France. | Industrial Machinery | Director/Board Member | |
L Catterton Europe SASU
 L Catterton Europe SASU Investment ManagersFinance L Catterton Europe SASU is a Private Equity firm, a subsidiary of Catterton Management Co. LLC founded in 1989 by Philippe Franchet. L Catterton Europe SASU is headquartered in Paris. | Investment Managers | Director of Investments | |
Innis & Gunn Holdings Ltd.
 Innis & Gunn Holdings Ltd. Beverages: AlcoholicConsumer Non-Durables Innis & Gunn Holdings Ltd. is a holding British company that produces and sells beer. The private company is based in Edinburgh, UK. and has subsidiaries in United Kingdom and Canada. The company was founded in 2007. | Beverages: Alcoholic | Director/Board Member | |
Mérieux Equity Partners SAS
 Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Investment Managers | Private Equity Investor | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Somfy Protect by Myfox SAS
 Somfy Protect by Myfox SAS Miscellaneous Commercial ServicesCommercial Services Somfy Protect by Myfox SAS develops and manufactures security systems. It designs and produces connected, sensor-driven and wireless home security equipment. The company was founded by Jean Prunet in 2005 and is headquartered in Labege, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Meanings Capital Partners
 Meanings Capital Partners Investment ManagersFinance Meanings Capital Partners is a private equity firm headquartered in Paris, France. It was founded in 2013 and is a wholly owned subsidiary of Meeschaert Asset Management SA. | Investment Managers | Private Equity Investor | |
| Argos Wityu SAS | Investment Managers | Private Equity Analyst | |
| WPP PLC | Advertising/Marketing Services | Sales & Marketing | |
| SOLVING EFESO INTL | Miscellaneous Commercial Services | Director/Board Member | |
| MICHELIN (CGDE) | Automotive Aftermarket | Corporate Officer/Principal | |
| Universite Paris Cite | College/University | Undergraduate Degree | |
SIGEFI Private Equity SA
 SIGEFI Private Equity SA Investment ManagersFinance SIGEFI Private Equity SA is an Independent Private Equity firm founded in 1985. SPE is headquartered in Lyon. | Investment Managers | Private Equity Investor | |
| INSEAD | College/University | Masters Business Admin | |
TechFund Capital
 TechFund Capital Investment ManagersFinance TechFund Capital (TechFund Capital) is a venture capital firm founded in 1997 by Kurt A. Keilhacker. The firm is headquartered in Saratoga, California, with additional office on Paris, France. | Investment Managers | Consultant / Advisor | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Director/Board Member | |
| SI PARTICIPATIONS S.C.A, SCR | Investment Managers | Director/Board Member | |
CentraleSupélec Exed SA
 CentraleSupélec Exed SA Other Consumer ServicesConsumer Services CentraleSupélec operates as a higher education and research institution. The firm is a public institution under ministerial charter, devoted to the sciences and engineering. The company was founded on January 1, 2015 and is headquartered in Paris, France. | College/University | Undergraduate Degree | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| École Centrale Paris | College/University | Undergraduate Degree | |
| Emory University | College/University | Undergraduate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree | |
| Waseda University | College/University | Graduate Degree |
Statistics
International
| France | 35 |
| United States | 6 |
| Switzerland | 4 |
| China | 3 |
| Israel | 3 |
Sectoral
| Consumer Services | 17 |
| Finance | 14 |
| Health Technology | 9 |
| Commercial Services | 4 |
| Consumer Durables | 3 |
Operational
| Director/Board Member | 107 |
| Private Equity Investor | 34 |
| Undergraduate Degree | 20 |
| Corporate Officer/Principal | 15 |
| Chief Executive Officer | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Bruno Bézard | 41 |
| Ming Po Cai | 32 |
| Eric Forquenot de la Fortelle | 19 |
| Hervé Stephane Descazeaux | 15 |
| Marc Jourlait | 11 |
| Hongjie Hu | 10 |
| Jérémie Falzone | 7 |
| Lanchun Duan | 7 |
| Jean-Marc Prunet | 6 |
| Edouard Moinet | 5 |
| Nicole FAUROT | 5 |
| Daniel Balmisse | 5 |
| Caroline Folleas | 5 |
| Charlie Naudy | 5 |
| Matthieu Elst | 4 |
- Stock Market
- Insiders
- Antoine Dauphin
- Company connections
